Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
HIV Clinical Trials|February 11, 2003
Comparison of metabolic abnormalities and clinical lipodystrophy 48 weeks after switching from HAART to Trizivir versus continued HAART: the Trizal studyAlain Lafeuillade, Nathan Clumeck, Josep Mallolas, et al.
AIDS (London, England)|June 26, 2003
Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphomaChristian Hoffmann, Eva Wolf, Gerd Fätkenheuer, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 20, 2012
Cost of HIV and determinants of health care costs in HIV-positive patients in Germany: results of the DAGNÄ K3A StudySarah Mostardt, Nikola Hanhoff, Jürgen Wasem, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 21, 2021
Functional Hypogonadism and Testosterone Deficiency in Aging Males With and Without HIV-infectionNils Postel, Eva Wolf, Annamaria Balogh, et al.
Psychology, Health & Medicine|February 13, 2018
Anxiety, depression, and health-related quality of life in aging people living with HIV compared to diabetes patients and patients with minor health conditions: a longitudinal studyJoram Ronel, Andreas Dinkel, Eva Wolf, et al.
HIV Research & Clinical Practice|September 20, 2019
Patient-reported tolerability and acceptability of cabotegravir + rilpivirine long-acting injections for the treatment of HIV-1 infection: 96-week results from the randomized LATTE-2 studyMiranda Murray, Federico Pulido, Anthony Mills, et al.
Inflammation & Allergy Drug Targets|February 18, 2012
Detection of abacavir hypersensitivity by ELISpot methodStefan Esser, Robert Jablonka, Falko M Heinemann, et al.
The Lancet. Infectious Diseases|October 1, 2013
Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trialFrançois Raffi, Hans Jaeger, Eugenia Quiros-Roldan, et al.
Frontiers in Immunology|May 16, 2018
Treatment Intensification in HIV-Infected Patients Is Associated With Reduced Frequencies of Regulatory T CellsEva M Grützner, Tanja Hoffmann, Eva Wolf, et al.
Antiviral Therapy|September 3, 2016
Dolutegravir monotherapy as treatment de-escalation in HIV-infected adults with virological control: DoluMono cohort resultsCelia Oldenbuettel, Eva Wolf, Ayla Ritter, et al.
Pageof 4